14-99174329-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP5
The NM_138576.4(BCL11B):c.2507G>A(p.Ser836Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_138576.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, G2P
- immunodeficiency 49Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BCL11B | ENST00000357195.8 | c.2507G>A | p.Ser836Asn | missense_variant | Exon 4 of 4 | 1 | NM_138576.4 | ENSP00000349723.3 | ||
| BCL11B | ENST00000345514.2 | c.2294G>A | p.Ser765Asn | missense_variant | Exon 3 of 3 | 1 | ENSP00000280435.6 | |||
| BCL11B | ENST00000443726.2 | c.1925G>A | p.Ser642Asn | missense_variant | Exon 2 of 2 | 5 | ENSP00000387419.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
BCL11B-related disorder Pathogenic:2
Variant summary: BCL11B c.2507G>A (p.Ser836Asn) results in a conservative amino acid change located in the C2H2 zinc finger domain (IPR056438) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250178 control chromosomes. c.2507G>A has been reported as a heterozgyous de novo occurance in individuals with clinical features of with BCL11B-Related Disorders (Pode-Shakked, Labcorp). The following publication(s) have been ascertained in the context of this evaluation (PMID: 34580403). ClinVar contains an entry for this variant (Variation ID: 1164020). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:1Uncertain:1
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 836 of the BCL11B protein (p.Ser836Asn). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of BCL11B-related features (PMID: 34580403). ClinVar contains an entry for this variant (Variation ID: 1164020). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on BCL11B protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at